Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Tor Henrik Tvedt, Ina Nepstad & Øystein Bruserud. (2017) Antileukemic effects of midostaurin in acute myeloid leukemia – the possible importance of multikinase inhibition in leukemic as well as nonleukemic stromal cells. Expert Opinion on Investigational Drugs 26:3, pages 343-355.
Read now
Read now
Çiğdem Akalin Akkök, Knut Liseth, Guro Kristin Melve, Elisabeth Ersvær, Tor Hervig & Øystein Bruserud. (2011) Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts?. Cytotherapy 13:8, pages 1013-1024.
Read now
Read now
Articles from other publishers (9)
Lene Russell, Lars Broksø Holst, Lars Kjeldsen, Jakob Stensballe & Anders Perner. (2017) Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies. Annals of Intensive Care 7:1.
Crossref
Crossref
Maria Ilaria Del Principe, Domenico Del Principe & Adriano Venditti. (2017) Thrombosis in adult patients with acute leukemia. Current Opinion in Oncology 29:6, pages 448-454.
Crossref
Crossref
MengJie Yan & Paul Jurasz. (2016) The role of platelets in the tumor microenvironment: From solid tumors to leukemia. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:3, pages 392-400.
Crossref
Crossref
Juliana Velez, Leonardo José Enciso, Marta Suarez, Michael Fiegl, Adriana Grismaldo, Catalina López, Alfonso Barreto, Claudia Cardozo, Pilar Palacios, Ludis Morales, Jorge Eduardo Duque, Jorge Uriel Carmona, Marina Konopleva, Michael Andreeff & Ismael Samudio. (2014) Platelets Promote Mitochondrial Uncoupling and Resistance to Apoptosis in Leukemia Cells: A Novel Paradigm for the Bone Marrow Microenvironment. Cancer Microenvironment 7:1-2, pages 79-90.
Crossref
Crossref
Brynjar Foss, Elling Ulvestad, Tor Hervig & �ystein Bruserud. (2002) Effects of cytarabine and various anthracyclins on platelet activation: Characterization ofin vitro effects and their possible clinical relevance in acute myelogenous leukemia. International Journal of Cancer 97:1, pages 106-114.
Crossref
Crossref
Brynjar Foss, Elling Ulvestad & Øystein Bruserud. (2001)
Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by
in vitro
cultured acute myelogenous leukemia blasts
. European Journal of Haematology 67:4, pages 267-278.
Crossref
Crossref
Brynjar Foss, Elling Ulvestad & Øystein Bruserud. (2001)
Platelet‐derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by
in vitro
cultured acute myelogenous leukemia blasts
. European Journal of Haematology 66:6, pages 365-376.
Crossref
Crossref
Øystein Bruserud, Bjørn Tore Gjertsen, Brynjar Foss & Tien‐Sheng Huang. (2009) New Strategies in the Treatment of Acute Myelogenous Leukemia (AML): In Vitro Culture of AML Cells—The Present Use in Experimental Studies and the Possible Importance for Future Therapeutic Approaches. STEM CELLS 19:1, pages 1-11.
Crossref
Crossref
Øystein Bruserud, Brynjar Foss, Jenny Foss Abrahamsen, Bjørn Tore Gjertsen & Peter Ernst. (2000) Autologous Stem Cell Transplantation As Post-Remission Therapy in Adult Acute Myelogenous Leukemia: Does Platelet Contamination of Peripheral Blood Mobilized Stem Cell Grafts Influence the Risk of Leukemia Relapse?. Journal of Hematotherapy & Stem Cell Research 9:4, pages 433-443.
Crossref
Crossref